• Home
  • Carboplatin and paclitaxel after anti-PD-1 or anti-PD-L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck.

Carboplatin and paclitaxel after anti-PD-1 or anti-PD-L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck.

Author List
Humphries A, Zhou CJ, Welsh M, Lem M, Kang H, Algazi AP
Publication
Head & neck
Publication ID (Profile URL)
https://researcherprofiles.org/profile/458954381
Publication Year
2023
PubMed ID
37997549
Publication Title
Humphries A, Zhou CJ, Welsh M, Lem M, Kang H, Algazi AP. Carboplatin and paclitaxel after anti-PD-1 or anti-PD-L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck. Head Neck. 2024 02; 46(2):321-327.